COMP <GO>
SNDX vs LBRX // NET PROFIT MARGIN
Syndax Pharmaceuticals Inc. (NASDAQ) VS. LB Pharmaceuticals Inc (NASDAQ) • 15-METRIC TALLY: SNDX 1
— LBRX 3
■ METRIC PARITY
LAST: $14.15 (-1.19%) • MKT CAP: $1.26B
net-margins
-60.00%
LAST: $40.15 (+0.80%) • MKT CAP: $1.30B
net-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNDX VS. LBRX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNDX | LBRX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -8.40% | -26.60 | LBRX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -2.72% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | SNDX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.8 | 52.9 | -17.18 | LBRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.26B | $1.30B | -$31.7M | LBRX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNDX REV | LBRX REV | SNDX GROSS % | LBRX GROSS % | SNDX FCF | LBRX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $172.4M | $0 | — | — | -$323.2M | -$35.3M |
| FY 2024 | $23.7M | $0 | — | — | -$274.9M | -$53.8M |
| FY 2023 | $0 | — | — | — | -$160.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNDX // BETA —
LBRX // BETA —